153 related articles for article (PubMed ID: 9794389)
1. IL-7 reconstitutes multiple aspects of v-Abl-mediated signaling.
Banerjee A; Rothman P
J Immunol; 1998 Nov; 161(9):4611-7. PubMed ID: 9794389
[TBL] [Abstract][Full Text] [Related]
2. Jak-STAT signaling induced by the v-abl oncogene.
Danial NN; Pernis A; Rothman PB
Science; 1995 Sep; 269(5232):1875-7. PubMed ID: 7569929
[TBL] [Abstract][Full Text] [Related]
3. An active v-abl protein tyrosine kinase blocks immunoglobulin light-chain gene rearrangement.
Chen YY; Wang LC; Huang MS; Rosenberg N
Genes Dev; 1994 Mar; 8(6):688-97. PubMed ID: 7926759
[TBL] [Abstract][Full Text] [Related]
4. Functional uncoupling of the Janus kinase 3-Stat5 pathway in malignant growth of human T cell leukemia virus type 1-transformed human T cells.
Kirken RA; Erwin RA; Wang L; Wang Y; Rui H; Farrar WL
J Immunol; 2000 Nov; 165(9):5097-104. PubMed ID: 11046040
[TBL] [Abstract][Full Text] [Related]
5. Temperature-sensitive transformation by an Abelson virus mutant encoding an altered SH2 domain.
Mainville CA; Parmar K; Unnikrishnan I; Gong L; Raffel GD; Rosenberg N
J Virol; 2001 Feb; 75(4):1816-23. PubMed ID: 11160680
[TBL] [Abstract][Full Text] [Related]
6. Cooperative and redundant effects of STAT5 and Ras signaling in BCR/ABL transformed hematopoietic cells.
Hoover RR; Gerlach MJ; Koh EY; Daley GQ
Oncogene; 2001 Sep; 20(41):5826-35. PubMed ID: 11593388
[TBL] [Abstract][Full Text] [Related]
7. Constitutive activation of STAT5 by the BCR-ABL oncogene in chronic myelogenous leukemia.
Shuai K; Halpern J; ten Hoeve J; Rao X; Sawyers CL
Oncogene; 1996 Jul; 13(2):247-54. PubMed ID: 8710363
[TBL] [Abstract][Full Text] [Related]
8. JAK-STAT signaling activated by Abl oncogenes.
Danial NN; Rothman P
Oncogene; 2000 May; 19(21):2523-31. PubMed ID: 10851051
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-7 signaling in human B cell precursor acute lymphoblastic leukemia cells and murine BAF3 cells involves activation of STAT1 and STAT5 mediated via the interleukin-7 receptor alpha chain.
van der Plas DC; Smiers F; Pouwels K; Hoefsloot LH; Löwenberg B; Touw IP
Leukemia; 1996 Aug; 10(8):1317-25. PubMed ID: 8709637
[TBL] [Abstract][Full Text] [Related]
10. Functional involvement of Akt signaling downstream of Jak1 in v-Abl-induced activation of hematopoietic cells.
Oki S; Limnander A; Danial NN; Rothman PB
Blood; 2002 Aug; 100(3):966-73. PubMed ID: 12130510
[TBL] [Abstract][Full Text] [Related]
11. STAT5-Dependent CyclinD1 and Bcl-xL expression in Bcr-Abl-transformed cells.
de Groot RP; Raaijmakers JA; Lammers JW; Koenderman L
Mol Cell Biol Res Commun; 2000 May; 3(5):299-305. PubMed ID: 10964754
[TBL] [Abstract][Full Text] [Related]
12. In vitro transformation of murine pro-B and pre-B cells by v-mpl, a truncated form of a cytokine receptor.
Fichelson S; Vigon I; Dusanter I; Charon M; Velu T; Baillou C; Gisselbrecht S; Lemoine FM
J Immunol; 1995 Feb; 154(4):1577-86. PubMed ID: 7836743
[TBL] [Abstract][Full Text] [Related]
13. The v-abl tyrosine kinase negatively regulates NF-kappa B/Rel factors and blocks kappa gene transcription in pre-B lymphocytes.
Klug CA; Gerety SJ; Shah PC; Chen YY; Rice NR; Rosenberg N; Singh H
Genes Dev; 1994 Mar; 8(6):678-87. PubMed ID: 7926758
[TBL] [Abstract][Full Text] [Related]
14. Cooperation between STAT5 and phosphatidylinositol 3-kinase in the IL-3-dependent survival of a bone marrow derived cell line.
Rosa Santos SC; Dumon S; Mayeux P; Gisselbrecht S; Gouilleux F
Oncogene; 2000 Feb; 19(9):1164-72. PubMed ID: 10713704
[TBL] [Abstract][Full Text] [Related]
15. Arrested development: understanding v-abl.
Kerr LD
Bioessays; 1994 Jul; 16(7):453-5. PubMed ID: 7945272
[TBL] [Abstract][Full Text] [Related]
16. Bcr-Abl has a greater intrinsic capacity than v-Abl to induce the neoplastic expansion of myeloid cells.
Gross AW; Ren R
Oncogene; 2000 Dec; 19(54):6286-96. PubMed ID: 11175343
[TBL] [Abstract][Full Text] [Related]
17. IL-3 dependent regulation of Bcl-xL gene expression by STAT5 in a bone marrow derived cell line.
Dumon S; Santos SC; Debierre-Grockiego F; Gouilleux-Gruart V; Cocault L; Boucheron C; Mollat P; Gisselbrecht S; Gouilleux F
Oncogene; 1999 Jul; 18(29):4191-9. PubMed ID: 10435632
[TBL] [Abstract][Full Text] [Related]
18. The carboxyl terminus of v-Abl protein can augment SH2 domain function.
Warren D; Heilpern AJ; Berg K; Rosenberg N
J Virol; 2000 May; 74(10):4495-504. PubMed ID: 10775585
[TBL] [Abstract][Full Text] [Related]
19. Lymphoid cells transformed by Abelson virus require the v-abl protein-tyrosine kinase only during early G1.
Chen YY; Rosenberg N
Proc Natl Acad Sci U S A; 1992 Aug; 89(15):6683-7. PubMed ID: 1379715
[TBL] [Abstract][Full Text] [Related]
20. STAT5 as a molecular regulator of proliferation, differentiation and apoptosis in hematopoietic cells.
Nosaka T; Kawashima T; Misawa K; Ikuta K; Mui AL; Kitamura T
EMBO J; 1999 Sep; 18(17):4754-65. PubMed ID: 10469654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
